Matches in SemOpenAlex for { <https://semopenalex.org/work/W2183323821> ?p ?o ?g. }
- W2183323821 endingPage "90" @default.
- W2183323821 startingPage "183" @default.
- W2183323821 abstract "Systemic IL-2 is an effective treatment for low to intermediate risk mRCC patients, its efficacy is marginal in high-risk cases. Therefore, other treatment approaches are required for this population. Ninety-four high-risk patients with RCC and pulmonary metastases were treated with inhaled plus concomitant low-dose subcutaneous rhIL-2. Clinical response, survival and safety were compared with those from IL-2 given systemically at the registered dose and schedule in 103 comparable historical controls. In the rhIL-2 INH group, treatment consisted of 6.5 MIU rhIL-2 nebulized 5x/day and 3.3 MIU rhIL-2 SC once daily. The rhIL-2 SYS group received treatment which consisted of intravenous infusion of 18.0 MIU/m2/day rhIL-2 or SC injection of 3.6-18.0 MIU rhIL-2. Some patients in both groups also received IFNalpha. Mean treatment durations were 43 weeks rhIL-2 INH and 15 weeks rhIL-2 SYS. Significantly longer overall survival and progression-free survival durations were observed in the rhIL-2 INH group. The probability of survival at 5 years was 21% for the rhIL-2 INH group. No patients survived 5 years in the rhIL-2 SYS group. A multivariate analysis of overall survival adjusting for differences in baseline characteristics between the two treatment groups resulted in a risk ratio of 0.43 (95% CI 0.30-0.63; P < 0.0001). The data suggested an association between the response (SD or better) and survival, especially in the rhIL-2 INH group. The inhalation regimen was well tolerated. This outcome study suggests that administration of rhIL-2 by inhalation is efficacious and safe in high-risk mRCC patients with pulmonary metastases, who have no other treatment option available." @default.
- W2183323821 created "2016-06-24" @default.
- W2183323821 creator A5003391568 @default.
- W2183323821 creator A5012637812 @default.
- W2183323821 creator A5013772332 @default.
- W2183323821 creator A5018146967 @default.
- W2183323821 creator A5018573703 @default.
- W2183323821 creator A5023957959 @default.
- W2183323821 creator A5031120597 @default.
- W2183323821 creator A5038783337 @default.
- W2183323821 creator A5046145687 @default.
- W2183323821 creator A5048118430 @default.
- W2183323821 creator A5051821128 @default.
- W2183323821 creator A5053276223 @default.
- W2183323821 creator A5053922377 @default.
- W2183323821 creator A5054654416 @default.
- W2183323821 creator A5054815405 @default.
- W2183323821 creator A5055067989 @default.
- W2183323821 creator A5055140503 @default.
- W2183323821 creator A5066679073 @default.
- W2183323821 creator A5068262794 @default.
- W2183323821 creator A5073359794 @default.
- W2183323821 creator A5074342534 @default.
- W2183323821 creator A5082213419 @default.
- W2183323821 creator A5083448346 @default.
- W2183323821 creator A5089661293 @default.
- W2183323821 date "2003-01-01" @default.
- W2183323821 modified "2023-10-01" @default.
- W2183323821 title "Efficacy and safety of inhaled recombinant interleukin-2 in high-risk renal cell cancer patients compared with systemic interleukin-2: an outcome study." @default.
- W2183323821 cites W145002737 @default.
- W2183323821 cites W1483649639 @default.
- W2183323821 cites W168641516 @default.
- W2183323821 cites W1884121283 @default.
- W2183323821 cites W1918446294 @default.
- W2183323821 cites W1957997736 @default.
- W2183323821 cites W1967884480 @default.
- W2183323821 cites W1975443078 @default.
- W2183323821 cites W1976969145 @default.
- W2183323821 cites W1985981664 @default.
- W2183323821 cites W2014322171 @default.
- W2183323821 cites W2023720862 @default.
- W2183323821 cites W2027888952 @default.
- W2183323821 cites W2037776650 @default.
- W2183323821 cites W2042107357 @default.
- W2183323821 cites W2049689068 @default.
- W2183323821 cites W2054305057 @default.
- W2183323821 cites W2063941399 @default.
- W2183323821 cites W2081171265 @default.
- W2183323821 cites W2087652370 @default.
- W2183323821 cites W2088391922 @default.
- W2183323821 cites W2091909257 @default.
- W2183323821 cites W2096509120 @default.
- W2183323821 cites W2133818380 @default.
- W2183323821 cites W2143813821 @default.
- W2183323821 cites W2150904418 @default.
- W2183323821 cites W2155221651 @default.
- W2183323821 cites W2158391991 @default.
- W2183323821 cites W2173123780 @default.
- W2183323821 cites W2295043466 @default.
- W2183323821 cites W2326245275 @default.
- W2183323821 cites W2340256585 @default.
- W2183323821 cites W2398385928 @default.
- W2183323821 cites W2409179504 @default.
- W2183323821 cites W2409321133 @default.
- W2183323821 cites W2414824833 @default.
- W2183323821 cites W2417751031 @default.
- W2183323821 cites W2460568636 @default.
- W2183323821 cites W2463959934 @default.
- W2183323821 cites W319745172 @default.
- W2183323821 cites W2398804065 @default.
- W2183323821 cites W2460517541 @default.
- W2183323821 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/14680292" @default.
- W2183323821 hasPublicationYear "2003" @default.
- W2183323821 type Work @default.
- W2183323821 sameAs 2183323821 @default.
- W2183323821 citedByCount "13" @default.
- W2183323821 countsByYear W21833238212015 @default.
- W2183323821 countsByYear W21833238212019 @default.
- W2183323821 countsByYear W21833238212022 @default.
- W2183323821 countsByYear W21833238212023 @default.
- W2183323821 crossrefType "journal-article" @default.
- W2183323821 hasAuthorship W2183323821A5003391568 @default.
- W2183323821 hasAuthorship W2183323821A5012637812 @default.
- W2183323821 hasAuthorship W2183323821A5013772332 @default.
- W2183323821 hasAuthorship W2183323821A5018146967 @default.
- W2183323821 hasAuthorship W2183323821A5018573703 @default.
- W2183323821 hasAuthorship W2183323821A5023957959 @default.
- W2183323821 hasAuthorship W2183323821A5031120597 @default.
- W2183323821 hasAuthorship W2183323821A5038783337 @default.
- W2183323821 hasAuthorship W2183323821A5046145687 @default.
- W2183323821 hasAuthorship W2183323821A5048118430 @default.
- W2183323821 hasAuthorship W2183323821A5051821128 @default.
- W2183323821 hasAuthorship W2183323821A5053276223 @default.
- W2183323821 hasAuthorship W2183323821A5053922377 @default.
- W2183323821 hasAuthorship W2183323821A5054654416 @default.
- W2183323821 hasAuthorship W2183323821A5054815405 @default.
- W2183323821 hasAuthorship W2183323821A5055067989 @default.
- W2183323821 hasAuthorship W2183323821A5055140503 @default.